Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
NCT05986136
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Inflammatory Bowel Diseases
Interventions
DRUG:
Mesalamine
DRUG:
Dapagliflozin 10mg Tab
Sponsor
Mostafa Bahaa